News

Everest Medicines unveils breakthroughs in AI+mRNA platform, reinforces global leadership in next-gen mRNA innovation: Hong Kong Monday, July 7, 2025, 10:00 Hrs [IST] Everest Medi ...
EMA & HMA issue recommendations to address vulnerabilities in the supply chain of anti-D immunoglobulins: Amsterdam, The Netherlands Monday, July 7, 2025, 09:00 Hrs [IST] The Euro ...
DCC gives nod to amend Rules related to licensing of stem cell derived & gene therapy products: Gireesh Babu, New Delhi Monday, July 7, 2025, 08:00 Hrs [IST] The Drugs Consultativ ...
Pharmexcil invites Croatia and Austria pharma delegation to explore iPHEX -2025 to enhance bilateral trade: Shardul Nautiyal, Mumbai Monday, July 7, 2025, 08:00 Hrs [IST] With rep ...
Imports of bulk drugs and intermediates to India have seen a decline for the second consecutive month in FY26, and a cumulative decline for the first two months of the fiscal year. The imports ...
In a significant initiative aimed at strengthening India’s research capacity in infectious disease surveillance and intervention, the Indian Council of Medical Research (ICMR)-National Institute for ...
The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has reported that India's pharmaceutical export continued its growth trajectory with USD 2,475.70 million in May 2025, cumulating to ...
Clearmind Medicine gets IRB nod from TASMC for phase 1/2a clinical trial to evaluate CMND-100 for treatment of alcohol use disorder: Vancouver, Canada Saturday, July 5, 2025, 18:0 ...
Ensem Therapeutics doses first patient in phase 1/2 clinical study of ETX-636, a novel allosteric pan-mutant-selective PI3Ka inhibitor and degrader: Waltham, Massachusetts Saturda ...
Invivyd, SPEAR Study Group to assess the effects of monoclonal antibody therapy for recent Covid & Covid-19 post-vaccination syndrome: Waltham, Massachusetts Saturday, July 5, 202 ...
Theratechnologies signs binding arrangement agreement with CB Biotechnology to buy all issued and outstanding common shares of the company: Montreal Saturday, July 5, 2025, 15:00 ...